These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 11652701)
1. State biotechnology oversight: the juncture of technology, law, and public policy. Vito CC Maine Law Rev; 1993; 45(2):329-83. PubMed ID: 11652701 [No Abstract] [Full Text] [Related]
2. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark. Baark E; Jamison A Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912 [No Abstract] [Full Text] [Related]
3. The emerging federalism of U.S. biotechnology policy. Webber DJ Politics Life Sci; 1995 Feb; 14(1):65-72. PubMed ID: 11654872 [No Abstract] [Full Text] [Related]
4. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after. Barkstrom JE Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740 [No Abstract] [Full Text] [Related]
5. The regulation of recombinant DNA research: the alternative of local control. Rosenblatt DP Boston Coll Environ Aff Law Rev; 1982; 10(1):37-78. PubMed ID: 11649694 [No Abstract] [Full Text] [Related]
6. Recombinant DNA and technology assessment. Georgetown Law J; 1977; 11(4):785-878. PubMed ID: 11664859 [No Abstract] [Full Text] [Related]
8. From Asilomar to industrial biotechnology: risks, reductionism and regulation. Krimsky S Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467 [No Abstract] [Full Text] [Related]
9. Recombinant DNA: triumph or Trojan horse? Holtzman E Man Med; 1977; 2(2):83-103, W7. PubMed ID: 12083131 [No Abstract] [Full Text] [Related]
10. Genetic engineering and related biotechnologies: scientific progress and public policy. Perpich JG Technol Soc; 1983; 5(1):27-49. PubMed ID: 11650684 [No Abstract] [Full Text] [Related]
11. Living inventions: animal patenting in the United States and Europe. Nelkin D Stanford Law Pol Rev; 1992-1993 Winter; 4():203-10. PubMed ID: 11652651 [No Abstract] [Full Text] [Related]
12. The impact of biotechnology on corporate law and regulation. Green HP Technol Soc; 1983; 5(2):87-94. PubMed ID: 11650687 [No Abstract] [Full Text] [Related]
13. The challenge of biotechnology. Gore A; Owens S Yale Law Policy Rev; 1985; 3(2):336-57. PubMed ID: 11652468 [No Abstract] [Full Text] [Related]
14. West Germany's gene law weakens role of public opinion. MacKenzie D New Sci; 1990 Apr; 126(1712):17. PubMed ID: 11655973 [No Abstract] [Full Text] [Related]
15. The ethics of patenting higher life forms. Hoffmaster B Intellect Prop J; 1988; 4():1-24. PubMed ID: 11652586 [No Abstract] [Full Text] [Related]
16. Introduction to recombinant DNA research, development and evolution of the NIH guidelines, and proposed legislation. Talbot B Univ Toledo Law Rev; 1981; 12(4):804-14. PubMed ID: 11649587 [No Abstract] [Full Text] [Related]
17. Dealing with experts: the recombinant DNA debate. Park B; Thacher S Sci People; 1977; 9(5):28-35. PubMed ID: 11662396 [No Abstract] [Full Text] [Related]
18. Molecular politics in a global economy. Wright S Politics Life Sci; 1996 Sep; 15(2):249-63. PubMed ID: 11654797 [No Abstract] [Full Text] [Related]
19. Recombinant DNA research and public policy. Walters Le Jurimetrics; 1979; 19(4):363-84. PubMed ID: 11651671 [No Abstract] [Full Text] [Related]
20. Biotechnology and the lawmakers. Schmitt H Technol Soc; 1983; 5(1):5-14. PubMed ID: 11650685 [No Abstract] [Full Text] [Related] [Next] [New Search]